Millie
your market intelligence analyst
Search Results
61 results
Your search is now limited to «New Treatments» expert search.
FeedNavigator (EU) 08/15/2019 14:37
IN BRIEF The traditional approach to integrating new therapies involves long, expensive roadmaps with evidence generation required for multiple stakeholders, most notably regulators and clinicians.
More from FeedNavigator (EU):
In type 1 diabetes, which affects 400,000 people in the UK, the pancreas stops producing insulin entirely (stock image) Forxiga is taken alongside insulin, and helps to keep blood sugar levels in the normal range.
More from Mail on Sunday (United Kingdom):
Allergan has launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion.
Healio News 07/01/2019 15:34
Top-line results from the TIMES 3 study demonstrate the experimental oral diabetes drug imeglimin achieved its primary safety and efficacy endpoints, according to a press release from Poxel and Sumitomo Dainippon Pharma Co. Imeglimin is an oxidative phosphorylation blocker that inhibits hepatic gluconeogenesis, increases muscle glucose uptake and restores normal insulin secretion ...
More from Healio News:
Business Wire 07/01/2019 08:00
Over the last 100 years, only incremental advances have been made to manage type 1 diabetes with insulin.
More from Business Wire:
The study of all identifiable proteins as a whole also known as proteomics is regarded as one of the most promising fields of biomedical research for the development of new treatments for an almost limitless range of diseases, including diabetes, cardiovascular disease and various forms of cancer.
More from Middle East North Africa Financial Network (MENAFN):
PR Newswire 06/27/2019 09:48
I think these drugs are a breakthrough for people living with type-2 diabetes and diabetic kidney disease, because they offer both kidney and cardio-protection.
More from PR Newswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications